Ras proteins, key regulators of growth, differentiation, and malignant transformation, recently have been implicated in synaptic function and region-specific learning and memory functions in the brain. Rap proteins, members of the Ras small G protein superfamily, can inhibit Ras signaling through the Ras͞Raf-1͞mitogen-activated protein (MAP) kinase pathway or, through B-Raf, can activate MAP kinase. Rap and Ras proteins both can be activated through guanine nucleotide exchange factors (GEFs). Many Ras GEFs, but to date only one Rap GEF, have been identified. We now report the cloning of a brain-enriched gene, CalDAG-GEFI, which has substrate specificity for Rap1A, dual binding domains for calcium (Ca 2؉ ) and diacylglycerol (DAG), and enriched expression in brain basal ganglia pathways and their axon-terminal regions. Expression of CalDAG-GEFI activates Rap1A and inhibits Ras-dependent activation of the Erk͞MAP kinase cascade in 293T cells. Ca 2؉ ionophore and phorbol ester strongly and additively enhance this Rap1A activation. By contrast, CalDAG-GEFII, a second CalDAG-GEF family member that we cloned and found identical to
The basal ganglia are centrally implicated in movement control and in forms of procedural learning related to habit formation (1, 2) . It is not yet known whether particular neurochemical specializations of the basal ganglia contribute to these behavioral functions. The basal ganglia do, however, have a unique double-inhibitory pathway design combined with abundant expression of neuromodulators in striatal neurons. A number of genes with differentially high expression in the striatum also have been identified (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . These include genes coding for proteins with signaling functions, such as adenylate cyclase V (3) and DARPP-32 (11) . In an effort to identify other cellular signaling molecules that could contribute to basal ganglia functions, we initiated a search for striatum-enriched transcripts by a differential display method (14) . Among the transcripts identified in this search were a family of genes characterized by the presence of a Ras superfamily guanine nucleotide exchange factor (GEF) domain. Because of the considerable evidence implicating Ras in neuroplasticity and synaptic transmission (15) (16) (17) (18) (19) (20) (21) (22) , we focused on identifying the functional properties and expression patterns of these genes. We report here on the characterization of CalDAG-GEFI (calcium-and diacylglycerol-regulated GEFI), a striatumenriched gene product that has binding domains for Ca 2ϩ and DAG, as well as a novel Ras superfamily GEF that targets Rap1 (23) (24) (25) (26) (27) (28) .
MATERIALS AND METHODS
cDNA Library Screening. Human full-length CalDAG-GEFI cDNAs were isolated from a human frontal cortex ZAPII cDNA library (Stratagene) and a U937 ZAPII cDNA library (provided by S. Volinia, Università degli Studi di Ferrara, Italy). Mouse full-length CalDAG-GEFI was identified in the mouse expressed sequence tag (EST) database (GenBank accession no. W71787). Rat full-length CalDAG-GEFII cDNA was isolated from a rat whole-brain ZAPII cDNA library (Stratagene) by using human CalDAG-GEFII as a probe. Mouse ESTs identified through BLAST searches were purchased from Genome Systems (St. Louis).
Northern Analysis of CalDAG-GEFI and CalDag-GEFII mRNA Levels. Northern blots were purchased from CLON-TECH. Probes used included human CalDAG-GEFI, 729-bp EcoRI fragment; human CalDAG-GEFII, 584-bp SacI and HindIII fragment; rat CalDAG-GEFI, 439-bp fragment of EST clone RBC565 (GenBank accession no. C06861), obtained from J. Takeda (Gunma University, Japan); and rat CalDAG-GEFII, 508-bp PCR amplified and subcloned fragment (nucleic acids 2541-3048).
Expression Vectors. Full-length mouse CalDAG-GEFI cDNA inserted into a pCMV-SPORT expression vector with a carboxyl-terminal FLAG epitope was used for transfection. A PCR-amplified fragment of rat CalDAG-GEFII was subcloned into a pCAGGS expression vector, provided by J. Miazaki (Osaka University, Japan), with the addition of His 6 -tag at its amino terminus, resulting in pCAGGS-HisCalDAGII. We used pEBG-Krev1 that expresses Rap1A as a fusion protein to glutathione S-transferase (GST) in mamma-
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Analysis of Guanine Nucleotides Bound to Ras-Family Proteins in Intact Cells. 293T cells were transfected by SuperFect (Qiagen) as described previously (28) with expression vectors for GST-tagged Ras-family proteins and with those for various GEFs. Cells were labeled 24 hr after transfection with 32 P i for 2 hr. In some experiments, cells were stimulated with either 10 M A23187 or 1 M phorbol 12-myristate 13-acetate (TPA) for 3 min. GST-tagged Ras-family proteins were collected from cell lysates with glutathione Sepharose. Guanine nucleotides bound to Ras-family proteins were separated by TLC.
Activation of Elk1. Activation of Elk1 was examined by the PathDetect Elk1 transreporting system (Stratagene). 293T cells were transfected with pFR-Luc and pFA-Elk1 with various expression vectors, and light output was detected and analyzed by the use of LAS1000 (Fuji).
Production of Monoclonal and Polyclonal Antibodies Against Mouse CalDAG-GEFI. His 6 -tagged mouse CalDAG-GEFI polypeptide (amino acids 349-608) was expressed in bacteria, purified over Ni 2ϩ -nitrilotriacetate-agarose (Qiagen), and then used to immunize BALB͞c mice. The resultant polyclonal antiserum was monitored by ELISA, Western blot, immunoprecipitation, and immunof luorescence assays on CalDAG-GEFI-transfected COS-7 cells. Hybridomas were generated by PEG (polyethylene glycol)-mediated fusion of donor splenocytes to the SP2͞O cell line. Positive hybridoma cell lines were identified by screening in the assays described above and purified by limiting dilution and single-cell cloning. We identified three hybridoma cell lines against mouse CalDAG-GEFI (mAbs 18B11, 2D9, and 18A7) in addition to the polyclonal fusion serum.
Immunohistochemistry. Lightly postfixed, cryostat-cut, 10-m thick sections were immunostained by the ABC (Vectastain kit) method for CalDAG-GEFI with mAbs 18B11 and 2D9 and the polyclonal fusion serum, for tyrosine hydroxylase (TH) with mAbs from Incstar (Stillwater, MN), and for opioid receptor with polyclonal antiserum from R. P. Elde (University of Minnesota, Minneapolis). In Situ Hybridization of CalDAG-GEFI to Rat Adult Brain Tissues. In situ hybridization was performed according to Simmons (29) . A 439-bp rat EST clone RBC565 (98.4% identical to mouse CalDAG-GEFI nucleic acids 1777-2216) was isolated by BLAST search and used for making RNA probes with 33 P-labeled UTP (2,000 Ci͞mmol, NEN; 1 Ci ϭ 37 GBq) and T3 and T7 RNA polymerase (Promega).
Lesion Studies. Injections of ibotenic acid (20 g͞l, 1.5 l per site, 5-day survival) were made unilaterally at two sites in the midlateral caudoputamen, with contralateral vehicle control injections. Unilateral subthalamic knife-cuts (with control contralateral thalamic knife-cuts) were made at an anteroposterior level between the entopeduncular nucleus and substantia nigra (1-and 3-day survivals). Brains were processed as above for CalDAG-GEFI and TH immunostaining.
RESULTS AND DISCUSSION
CalDAG-GEFI encodes an approximately 69-kDa protein (Fig. 1D ) that displays in its amino-terminal region a GEF domain that is highly homologous to Ras-superfamily GEFs (30) (Fig. 1 A-D) . Multiple alignment analysis shows that genes of the CalDAG-GEF family form a cluster within the Ras-GEF superfamily distinct from Ras GEFs such as Sos1 and rRas-GEF (Fig. 1B) . The region downstream of the GEF domain contains two tandem repeats of EF-hand Ca 2ϩ -binding motifs (31) (Fig. 1 A and E) . The carboxyl-terminal region displays a typical DAG͞phorbol ester-binding domain, which is present in most PKC family proteins (32) (Fig. 1 A and F) .
To determine the small G protein target of CalDAG-GEFI, we analyzed guanine nucleotide exchange activity in vivo with intact 293T cells cotransfected with a eukaryotic expression construct of mouse CalDAG-GEFI and GST-tagged Rasfamily proteins (28, 33) . CalDAG-GEFI transfection produced a dramatic increase in GTP-bound Rap1A compared with control but showed no or minimal activation of H-Ras, R-Ras, or Ral A (Fig. 2A) . The increase in GTP-bound Rap1A was augmented in the presence of either the Ca 2ϩ ionophore A23187 or the phorbol ester TPA. Further, A23187 and TPA had additive effects when administered together (Fig. 2B) .
To determine the effect of CalDAG-GEFI on the Erk͞MAP kinase cascade, we measured Elk1 activation in 293T cells transfected with CalDAG-GEFI or constitutively active H-Ras (RasV12), or both. CalDAG-GEFI reduced RasV12 activation of Elk1 by Ϸ4-fold and did not itself activate Elk1 (Fig. 3) . Thus, CalDAG-GEFI strongly inhibits Ras-dependent stimulation of the Erk͞MAP kinase cascade.
Northern analysis showed that human CalDAG-GEFI is expressed strongly in the brain and that CalDAG-GEFI mRNA is strikingly enriched in the striatum (Fig. 4A) . Weaker hybridization was detectable elsewhere. In situ hybridization of sections from the adult rat brain confirmed these restricted distribution patterns (Fig. 5 A and AЈ) . Intense signal was present in the striatum (caudoputamen) and the ventral striatum (nucleus accumbens, olfactory tubercle). There was a weaker signal in the olfactory bulb and in some other sites (Fig.  5A) .
A series of mAbs against the carboxyl-terminal half of mouse CalDAG-GEFI was raised. Western analysis showed that mAbs 18B11 and 2D9 were specific for CalDAG-GEFI. Immunohistochemistry with mAb 18B11 showed a striking basal ganglia-enriched distribution pattern in sections of adult rat brain, with significant but weaker activity elsewhere (Fig. 5  B-DЈ) . CalDAG-GEFI immunoreactivity marked the entire pathway from the striatal matrix compartment to the pallidum and substantia nigra pars reticulata, where very intense CalDAG-GEFI staining was present (Fig. 5B ). This pattern, taken together with the in situ hybridization data, strongly suggests that CalDAG-GEFI is synthesized in striatal projection neurons and is transported to striatopallidal and striatonigral terminals. We tested this possibility in rats by making unilateral intrastriatal injections of ibotenic acid and, in other rats, by making subthalamic knife-cuts to sever striatonigral efferents. These procedures all reduced CalDAG-GEFI staining in the substantia nigra (Fig. 5 E-FЈ) , indicating that CalDAG-GEFI is a protein transported in striatal axons to their terminals. The terminal localization of CalDAG-GEFI was confirmed in subcellular fractionation experiments on dissected samples from the rat ventral midbrain, in which Western analysis showed the presence of CalDAG-GEFI in cytosol and in membrane fractions, including synaptosomes (data not shown).
Because of the similarity of the GEF domains of CalDAG-GEFI and CalDAG-GEFII (Fig. 1C) , we examined the substrate specificity of CalDAG-GEFII with the same 293T cell assay system used for CalDAG-GEFI. We confirmed that CalDAG-GEFII can activate Ras (34) , and further showed that it can activate H-Ras and R-Ras, but not Ral A or Rap1A (Fig. 2C ). H-Ras activation was enhanced by A23187 and TPA (Fig. 2D) . Moreover, CalDAG-GEFII, unlike CalDAG-GEFI, increased the transcriptional activity of Elk1 downstream to Erk͞MAP kinase (Fig. 3) . Thus, in the 293T system, CalDAG-GEFI and CalDag-GEFII target different Ras-superfamily small G proteins and have opposite effects on the MAP kinase cascade. Northern analysis further showed contrasting brain expression for CalDAG-GEFII, with highest expression being in the cerebellum, cerebral cortex, and amygdala, and low expression occurring in the striatum (Fig. 4C) . Interestingly, both genes also are expressed in hematopoietic organs in both human and rat (Fig. 6A-D) .
Our findings have significance of two sorts. First, they suggest that Rap signaling may be important in regulating basal ganglia output in response to Ca 2ϩ and DAG. It is known that corticostriatal inputs can activate the MAP kinase cascade in striatal projection neurons (35) and that phosphoinositide (PI) signaling is represented strongly in these pathways (36) . Moreover, a number of receptor systems in the striatum and its striatonigral͞striatopallidal pathways are linked to Ca 2ϩ and PI signaling, notably including N-methyl-D-aspartate and metabotropic glutamate receptors, D 2 -class dopamine receptors, and tachykinin receptors (37, 38) . Our experiments suggest that a previously unrecognized signaling target for some of these systems is likely to be Rap1, via CalDAG-GEFI. Our evidence for heavy accumulation of CalDAG-GEFI in the target nuclei of striatal outputs raises the possibility that CalDAG-GEFI has a synaptic function. The reported localization of Rap1 in synaptosomes and synaptic vesicles (39) supports this view. The particular basal ganglia projection systems that we have identified as enriched in CalDAG-GEFI are differentially vulnerable to neurodegeneration in Huntington's disease. Rap͞Ras function in these pathways should be considered in analyzing this vulnerability and growth factorbased therapeutic strategies (40) .
A second and more general implication of our findings is that Rap and Ras functions can be regulated coordinately or disjunctively by Ca 2ϩ and DAG in the brain and hematopoietic organs, depending on the relative expression of CalDAG-GEFI and CalDAG-GEFII. In neurons, Ras͞MAP kinase signaling has been implicated directly in synaptic transmission and the neuroplasticity underlying learning and memory (15) (16) (17) (18) (19) (20) (21) (22) . Different CalDAG-GEFI and CalDAG-GEFII expression patterns in the brain may critically influence region-specific neuroplasticity mediated by Ca 2ϩ -and DAG-signaling pathways. The presence of CalDAG-GEFI and CalDAG-GEFII in the hematopoietic system further suggests a direct input of Ca 2ϩ and DAG to Ras͞Rap regulation of normal growth and differentiation as well as malignant transformation.
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